EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 25 / No 1 (Janvier 2009) Med Sci (Paris), 25 1 (2009) 57-63 References
Free Access
Issue
Med Sci (Paris)
Volume 25, Number 1, Janvier 2009
Page(s) 57 - 63
Section M/S revues
DOI https://doi.org/10.1051/medsci/200925157
Published online 15 January 2009
  1. Katan MB, Zock PL, Mensink RP. Effects of fats and fatty acids on blood lipids in humans: an overview. Am J Clin Nutr 1994; 60 : S1017–22. [Google Scholar]
  2. Gnädig S, Chardigny JM, Sébédio JL. Lipides. In : Lait, Nutrition et Santé. Paris : Lavoisier Éditions, 2001. [Google Scholar]
  3. Rioux V, Catheline D, Legrand P. In rat hepatocytes, myristic acid occurs through lipogenesis, palmitic shortening and lauric acid elongation. Animal 2007; 1 : 820–6. [Google Scholar]
  4. Rioux V, Lemarchal P, Legrand P. Myristic acid, unlike palmitic acid, is rapidly metabolized in cultured rat hepatocytes. J Nutr Biochem 2000; 11 : 198–207. [Google Scholar]
  5. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992; 12 : 911–9. [Google Scholar]
  6. Tholstrup T, Vessby B, Sandstrom B. Difference in effect of myristic and stearic acid on plasma HDL cholesterol within 24 h in young men. Eur J Clin Nutr 2003; 57 : 735–42. [Google Scholar]
  7. Rioux V, Catheline D, Bouriel M, Legrand P. Dietary myristic acid at physiologically relevant levels increases the tissue content of C20:5 n-3 and C20:3 n-6 in the rat. Reprod Nutr Dev 2005; 45 : 599–612. [Google Scholar]
  8. Johnson DR, Bhatnagar RS, Knoll LJ, Gordon JI. Genetic and biochemical studies of protein N-myristoylation. Annu Rev Biochem 1994; 63 : 869–914. [Google Scholar]
  9. Giang DK, Cravatt BF. A second mammalian N-myristoyltransferase. J Biol Chem 1998; 273 : 6595–8. [Google Scholar]
  10. McIlhinney RA, Young K, Egerton M, et al. Characterization of human and rat brain myristoyl-CoA:protein N-myristoyltransferase: evidence for an alternative splice variant of the enzyme. Biochem J 1998; 333 : 491–5. [Google Scholar]
  11. Rioux V, Beauchamp E, Pedrono F, et al. Identification and characterization of recombinant and native rat myristoyl-CoA: protein N-myristoyltransferases. Mol Cell Biochem 2006; 286 : 161–70. [Google Scholar]
  12. Kishore NS, Lu TB, Knoll LJ, et al. The substrate specificity of Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase. Analysis of myristic acid analogs containing oxygen, sulfur, double bonds, triple bonds, and/or an aromatic residue. J Biol Chem 1991; 266 : 8835–55. [Google Scholar]
  13. Bhatnagar RS, Futterer K, Waksman G, Gordon JI. The structure of myristoyl-CoA:protein N-myristoyltransferase. Biochim Biophys Acta 1999; 1441 : 162–72. [Google Scholar]
  14. Faergeman NJ, Knudsen J. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. Biochem J 1997; 323 : 1–12. [Google Scholar]
  15. Rioux V, Galat A, Jan G, et al. Exogenous myristic acid acylates proteins in cultured rat hepatocytes. J Nutr Biochem 2002; 13 : 66–74. [Google Scholar]
  16. Duronio RJ, Rudnick DA, Johnson RL, et al. Myristic acid auxotrophy caused by mutation of S. cerevisiae myristoyl-CoA:protein N-myristoyltransferase. J Cell Biol 1991; 113 : 1313–30. [Google Scholar]
  17. Kokame K, Fukada Y, Yoshizawa T, et al. Lipid modification at the N terminus of photoreceptor G-protein alpha-subunit. Nature 1992; 359 : 749–52. [Google Scholar]
  18. DeMar JC Jr, Anderson RE. Identification and quantitation of the fatty acids composing the CoA ester pool of bovine retina, heart, and liver. J Biol Chem 1997; 272 : 31362–8. [Google Scholar]
  19. Zha J, Weiler S, Oh KJ, et al. Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science 2000; 290 : 1761–5. [Google Scholar]
  20. Maurer-Stroh S, Gouda M, Novatchkova M, et al. MYRbase: analysis of genome-wide glycine myristoylation enlarges the functional spectrum of eukaryotic myristoylated proteins. Genome Biol 2004; 5 : R21. [Google Scholar]
  21. Boutin JA. Myristoylation. Cell Signal 1997; 9 : 15–35. [Google Scholar]
  22. Ntwasa M, Aapies S, Schiffmann DA, Gay NJ. Drosophila embryos lacking N-myristoyltransferase have multiple developmental defects. Exp Cell Res 2001; 262 : 134–44. [Google Scholar]
  23. Yang SH, Shrivastav A, Kosinski C, et al. N-myristoyltransferase 1 is essential in early mouse development. J Biol Chem 2005; 280 : 18990–5. [Google Scholar]
  24. Sennequier N, Vadon-Le Goff S. Biosynthèse de monoxyde d’azote (NO) : mécanisme, régulation et contrôle. Med Sci (Paris) 1998; 14 : 1185–95. [Google Scholar]
  25. Shaul PW, Smart EJ, Robinson LJ, et al. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem 1996; 271 : 6518–22. [Google Scholar]
  26. Busconi L, Michel T. Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization. J Biol Chem 1993; 268 : 8410–3. [Google Scholar]
  27. Robinson LJ, Busconi L, Michel T. Agonist-modulated palmitoylation of endothelial nitric oxide synthase. J Biol Chem 1995; 270 : 995–8. [Google Scholar]
  28. Gonzalez E, Kou R, Lin AJ, et al. Subcellular targeting and agonist-induced site-specific phosphorylation of endothelial nitric-oxide synthase. J Biol Chem 2002; 277 : 39554–60. [Google Scholar]
  29. Zhu W, Smart EJ. Myristic acid stimulates endothelial nitric-oxide synthase in a CD36- and an AMP kinase-dependent manner. J Biol Chem 2005; 280 : 29543–50. [Google Scholar]
  30. Laugerette F, Passilly-Degrace P, Patris B, Niot I, Montmayeur JP, Besnard P. CD36, un sérieux jalon sur la piste du goût du gras. Med Sci (Paris) 2006; 22 : 357–9. [Google Scholar]
  31. Isenberg JS, Jia Y, Fukuyama J, et al. Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake. J Biol Chem 2007; 282 : 15404–15. [Google Scholar]
  32. Gong M, Wilson M, Kelly T, et al. HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner. J Clin Invest 2003; 111 : 1579–87. [Google Scholar]
  33. White J, Guerin T, Swanson H, et al. Diabetic HDL-associated myristic acid inhibits acetylcholine-induced nitric oxide generation by preventing the association of endothelial nitric oxide synthase with calmodulin. Am J Physiol Cell Physiol 2008; 294 : C295–305. [Google Scholar]
  34. Harris WS, Von Schacky C. The omega-3 index: a new risk factor for death from coronary heart disease ? Prev Med 2004; 39 : 212–20. [Google Scholar]
  35. Bourre JM. Enrichissement de l’alimentation des animaux avec les acides gras omega-3 : impact sur la valeur nutritionnelle de leurs produits pour l’homme. Med Sci (Paris) 2005; 21 : 773–9. [Google Scholar]
  36. Jan S, Guillou H, D’Andrea S, et al. Myristic acid increases delta6-desaturase activity in cultured rat hepatocytes. Reprod Nutr Dev 2004; 44 : 131–40. [Google Scholar]
  37. Rioux V, Catheline D, Beauchamp E, et al. Substitution of dietary oleic for myristic acid increases the tissue storage of alfa-linolenic acid and the concentration of docosahexaenoic acid in brain, red blood cells and plama in the rat. Animal 2008; 2 : 636–44. [Google Scholar]
  38. Porta N, Auvin S. Acides gras polyinsaturés: propriétés et mécanismes anticonvulsivants. Med Sci (Paris) 2009; 25 : 51–6. [Google Scholar]
  39. Dabadie H, Peuchant E, Bernard M, et al. Moderate intake of myristic acid in sn-2 position has beneficial lipidic effects and enhances DHA of cholesteryl esters in an interventional study. J Nutr Biochem 2005; 16 : 375–82. [Google Scholar]
  40. Beauchamp E, Goenaga D, Le Bloc’h J, et al. Myristic acid increases the activity of dihydroceramide Delta4-desaturase 1 through its N-terminal myristoylation. Biochimie 2007; 89 : 1553–61. [Google Scholar]
  41. Borgese N, Aggujaro D, Carrera P, et al. A role for N-myristoylation in protein targeting: NADH-cytochrome b5 reductase requires myristic acid for association with outer mitochondrial but not ER membranes. J Cell Biol 1996; 135 : 1501–13. [Google Scholar]
  42. Stiban J, Fistere D, Colombini M. Dihydroceramide hinders ceramide channel formation: implications on apoptosis. Apoptosis 2006; 11 : 773–80. [Google Scholar]
  43. Corbin A, Grigorov B, Roingeard P, et al. Une nouvelle vision de l’assemblage du VIH-1. Med Sci (Paris) 2008; 24 : 49–55. [Google Scholar]
  44. Henderson LE, Bowers MA, Sowder RC 2nd, et al. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1 : posttranslational modifications, proteolytic processings, and complete amino acid sequences. J Virol 1992; 66 : 1856–65. [Google Scholar]
  45. Schultz AM, Oroszlan S. In vivo modification of retroviral gag gene-encoded polyproteins by myristic acid. J Virol 1983; 46 : 355–61. [Google Scholar]
  46. Takamune N, Gota K, Misumi S, et al. HIV-1 production is specifically associated with human NMT1 long form in human NMT isozymes. Microbes Infect 2008; 10 : 143–50. [Google Scholar]
  47. Seaton KE, Smith CD. N-Myristoyltransferase isozymes exhibit differential specificity for human immunodeficiency virus type 1 Gag and Nef. J Gen Virol 2008; 89 : 288–96. [Google Scholar]
  48. Spearman P, Horton R, Ratner L, Kuli-Zade I. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. J Virol 1997; 71 : 6582–92. [Google Scholar]
  49. Boutin JA. La N-myristoyl transférase, carrefour entre virologie et oncologie: une voie d’accès à des anticancéreux et à des antiviraux d’un genre nouveau ? Med Sci (Paris) 1993; 9 : 684–92. [Google Scholar]
  50. Lindwasser OW, Resh MD. Myristoylation as a target for inhibiting HIV assembly: unsaturated fatty acids block viral budding. Proc Natl Acad Sci USA 2002; 99 : 13037–42. [Google Scholar]
  51. Morikawa Y, Hinata S, Tomoda H, et al. Complete inhibition of human immunodeficiency virus Gag myristoylation is necessary for inhibition of particle budding. J Biol Chem 1996; 271 : 2868–73. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.